Prevention of simian immunodeficiency virus, SIVsm, or HIV-2 infection in cynomolgus monkeys by pre- and postexposure administration of BEA-005

AIDS. 1997 Feb;11(2):157-62. doi: 10.1097/00002030-199702000-00004.

Abstract

Objective: To study the possibilities and limitations of postexposure treatment to prevent the establishment of infection after accidental exposure to HIV.

Design and methods: The effect of 2,3'-dideoxy-3'-hydroxymethyl cytidine (B1 A-005) was investigated on acute simian immunodeficiency virus (SIV) and HIV-2 infections in macaques in pre- and postexposure treatment experiments.

Results: Postexposure treatment with BLA-005 (3 x 10 mg/kg) for as short as 3 days prevented infection with SIVsm after intravenous or rectal inoculation. Infection with HIV-2 could also be blocked by postexposure BFA-005 treatment.

Conclusion: This study shows that therapeutic intervention can block early systemic and mucosal infections with SIV and HIV-2. Further evaluation is ongoing.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-HIV Agents / therapeutic use*
  • Antiviral Agents / therapeutic use*
  • Cytidine / analogs & derivatives*
  • Cytidine / therapeutic use
  • HIV Infections / prevention & control*
  • HIV Infections / virology
  • HIV-2 / isolation & purification*
  • Macaca fascicularis
  • Simian Acquired Immunodeficiency Syndrome / prevention & control*

Substances

  • 2',3'-dideoxy-3'-hydroxymethyl cytidine
  • Anti-HIV Agents
  • Antiviral Agents
  • Cytidine